In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
 

Heart Failure 2018

ESC TV @ Heart Failure 2018 - Vienna, Austria

Key messages, daily wrap-ups and perspectives from world-renowned experts


Acute heart failure - When drugs alone are not enough Acute heart failure - When drugs alone are not enough
Advanced heart failure - The new HFA consensus Advanced heart failure - The new HFA consensus
Cardiac contractility modulation improves long-term survival and hospitalisations in heart failure with reduced ejection fraction Cardiac contractility modulation improves long-term survival and hospitalisations in heart failure with reduced ejection fraction
Controversies in the definition and management of heart failure Controversies in the definition and management of heart failure
Diabetes and heart failure - A 21st century global challenge Diabetes and heart failure - A 21st century global challenge
Diabetes and obesity in heart failure Diabetes and obesity in heart failure
Digital Health & Heart Failure Digital Health & Heart Failure
European Journal of Heart Failure - The year's best papers on heart failure European Journal of Heart Failure - The year's best papers on heart failure
Heart failure as a major local and global challenge in the 21st century Heart failure as a major local and global challenge in the 21st century
Highlights of Day 1 Highlights of Day 1
Highlights of Day 3 Highlights of Day 3
Improve management of heart failure with procalcitonin Improve management of heart failure with procalcitonin
Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist device Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure and a left ventricular assist device
Primary results from REPORT-H, a worldwide, prospective heart failure disease registry Primary results from REPORT-H, a worldwide, prospective heart failure disease registry
Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial Rivaroxaban plus aspirin in patients with and without heart failure and chronic coronary or peripheral artery disease: the COMPASS trial
Splanchnic nerve block for acute heart failure Splanchnic nerve block for acute heart failure
The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming The HF-Wii study: Improving exercise capacity of patients with heart failure through exergaming
The new HFA definition of HFpEF The new HFA definition of HFpEF
Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II



About the ESC
Press and Media
Information
Follow us

         

 Help centre

 Contact us

© 2022 European Society of Cardiology. All rights reserved.